Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10896248rdf:typepubmed:Citationlld:pubmed
pubmed-article:10896248lifeskim:mentionsumls-concept:C0040052lld:lifeskim
pubmed-article:10896248lifeskim:mentionsumls-concept:C0042071lld:lifeskim
pubmed-article:10896248lifeskim:mentionsumls-concept:C0016016lld:lifeskim
pubmed-article:10896248lifeskim:mentionsumls-concept:C0040018lld:lifeskim
pubmed-article:10896248lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:10896248lifeskim:mentionsumls-concept:C0597304lld:lifeskim
pubmed-article:10896248lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:10896248lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:10896248pubmed:issue6lld:pubmed
pubmed-article:10896248pubmed:dateCreated2000-12-11lld:pubmed
pubmed-article:10896248pubmed:abstractTextSeveral observations suggest that limited proteolysis of full-length 70 kD human thrombopoietin (Tpo) may be important for Tpo biology. Recently, it was reported that thrombin cleaves full-length recombinant human Tpo (rhTpo) sequentially at two sites, Arg(195) within the glycan domain followed by Arg(117) within the cytokine domain, and that these cleavages modulate Tpo activity in vitro. We demonstrate that urokinase and plasmin also cleave rhTpo in a time-dependent manner. Urokinase cleavage is confined to the glycan domain, and generates a 35 kD N-terminal fragment that contains the intact cytokine domain, and is associated with increased Tpo activity. In contrast, plasmin cleaves Tpo sequentially at two specific sites (Arg(205) within the glycan domain followed by Lys(52) within the cytokine domain), and is associated with a marked decrease in Tpo activity. These proteolytic events have potential implications for regulation of Tpo activity in vivo.lld:pubmed
pubmed-article:10896248pubmed:languageenglld:pubmed
pubmed-article:10896248pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896248pubmed:citationSubsetIMlld:pubmed
pubmed-article:10896248pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896248pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896248pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896248pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896248pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896248pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896248pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896248pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896248pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896248pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896248pubmed:statusMEDLINElld:pubmed
pubmed-article:10896248pubmed:monthJunlld:pubmed
pubmed-article:10896248pubmed:issn0340-6245lld:pubmed
pubmed-article:10896248pubmed:authorpubmed-author:ReinerA PAPlld:pubmed
pubmed-article:10896248pubmed:authorpubmed-author:AramakiK MKMlld:pubmed
pubmed-article:10896248pubmed:issnTypePrintlld:pubmed
pubmed-article:10896248pubmed:volume83lld:pubmed
pubmed-article:10896248pubmed:ownerNLMlld:pubmed
pubmed-article:10896248pubmed:authorsCompleteYlld:pubmed
pubmed-article:10896248pubmed:pagination909-14lld:pubmed
pubmed-article:10896248pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:meshHeadingpubmed-meshheading:10896248...lld:pubmed
pubmed-article:10896248pubmed:year2000lld:pubmed
pubmed-article:10896248pubmed:articleTitleProteolytic modulation of thrombopoietin activity: comparison of thrombin, plasmin, and urokinase.lld:pubmed
pubmed-article:10896248pubmed:affiliationDepartment of Medicine, University of Washington, Seattle 98195, USA. apreiner@u.washington.edulld:pubmed
pubmed-article:10896248pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10896248pubmed:publicationTypeComparative Studylld:pubmed
entrez-gene:2147entrezgene:pubmedpubmed-article:10896248lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10896248lld:pubmed